Programmable Medicine develops Hydroxyl Dendrimer Therapeutics (HDTs), a clinically validated nanomedicine platform that selectively targets activated inflammatory cells without a targeting ligand minimizing off-target toxicity to normal cells.
| Website | https://www.pmed.com |
| Employees | 19 (8 on RocketReach) |
| Industry | Biotechnology Research |
Looking for a particular Programmable Medicine employee's phone or email?
Programmable Medicine Questions
Benson Lu is the Director of in vivo pharmacology of Programmable Medicine.
8 people are employed at Programmable Medicine.
Top Programmable Medicine Employees
-
Benson Lu
Director of in vivo pharmacology at Programmable Medicine
San Francisco, CA, US23 -
15
-
Michaela C.
Senior Director, Corporate Controller at Programmable Medicine
Emeryville, CA, US -
Madhuri Chattopadhyay
Senior Scientist II at Programmable Medicine
Palo Alto, CA, US22 -
Nirvani Mujumdar
Sr. Scientist, Analytical Development at Programmable Medicine
California, United States33 -
32
-
Cindy Yang
Senior Scientist at Programmable Medicine
San Francisco, CA, US23
G2Crowd Trusted
300K+
Plugin Users
